Marico Limited lifts Cosmix Wellness stake to 80% for Rs 113.65 crore

Marico Limited lifted its holding in Cosmix Wellness Private Limited to 80% on November 6, 2026, by paying Rs 113.65 crore in cash for a further 20% of paid-up share capital, and it has the right to acquire the remaining 20% after FY29 subject to milestones, approvals and definitive-agreement terms.

Why did Marico increase its Cosmix Wellness stake?

Marico increased its stake to add a digital-first functional wellness brand to its premium food and nutrition portfolio, according to the November 6, 2026 disclosure. Cosmix Wellness operates in the health and wellness industry, and Marico said its earlier 60% acquisition had enabled an expansion of its presence in premium food and nutrition categories.

Cosmix Wellness was incorporated on January 31, 2022, under the Companies Act, 2013, and is headquartered in Bengaluru. Marico describes Cosmix Wellness as owning one of India’s leading digital-first functional wellness brands, although the filing does not identify individual products, customer metrics, profitability or overseas operations.

The transaction was disclosed under Regulation 30 of the Securities and Exchange Board of India, or SEBI, Listing Obligations and Disclosure Requirements Regulations, 2015. Marico classified the November 6, 2026 acquisition as a related-party transaction undertaken on an arm’s-length basis and said its promoter and promoter group had no interest in the transaction.

How much did Marico pay and what stake does it own?

Marico paid aggregate cash consideration of Rs 113.65 crore for the additional 20% holding, taking its aggregate stake in Cosmix Wellness from 60% to 80% of paid-up share capital. The company said the acquisition was completed on November 6, 2026, rather than remaining a proposed share purchase.

The Rs 113.65 crore consideration applies to this 20% transaction, but the filing does not disclose the price paid for the initial 60% acquisition announced in February 2026. It also does not state the number of shares acquired, total paid-up share capital, a standalone valuation or any deferred-payment component.

No governmental or regulatory approvals were required for the 20% acquisition, according to the annexure to the November 6, 2026 filing. The reported completion therefore coincided with Marico’s increase to 80%, while the detailed conditions of the definitive agreement were not included in the two-page announcement.

How has Cosmix Wellness grown before Marico’s latest purchase?

Cosmix Wellness reported turnover of Rs 91.53 crore in FY 2025-26, compared with Rs 47.25 crore in FY 2024-25 and Rs 24.32 crore in FY 2023-24. Turnover rose by Rs 44.28 crore in FY 2025-26 from the preceding year, after increasing by Rs 22.93 crore in FY 2024-25 from FY 2023-24.

The absolute increase in FY 2025-26 was therefore Rs 21.35 crore larger than the increase reported in FY 2024-25. The filing reports turnover rather than profit, cash flow, gross margin, advertising expenditure or retention measures, so it does not set out Cosmix Wellness’ earnings contribution to Marico.

The FY 2023-24 turnover figure was calculated under Indian Generally Accepted Accounting Principles, or Indian GAAP. The filing also says Cosmix Wellness’ annual recurring revenue, or ARR, for the last three months was Rs 170+ crore under Indian Accounting Standards, or Ind AS, but does not specify the three-month period, calculation method or a prior comparable ARR figure.

Can Marico buy the remaining Cosmix Wellness stake?

Marico has the right to acquire the remaining 20% of Cosmix Wellness after completion of FY29, with the consideration to be determined at that time. The potential purchase is subject to certain milestones, requisite approvals and the terms and conditions in the definitive agreements.

The November 6, 2026 purchase thus raises Marico’s ownership to 80% but does not complete an acquisition of 100%. The filing does not identify the milestones, provide a valuation formula, state a precise exercise date after FY29 or say whether Marico is obliged to acquire the final 20%.

The structure separates the Rs 113.65 crore paid for the completed 20% transaction from the future consideration for the remaining stake. That future amount cannot be inferred from the November 2026 price because the disclosure says it will be determined after FY29 and remains conditional on milestones, approvals and agreement terms.

What does the transaction say about Marico’s ownership strategy?

Marico’s November 2026 transaction follows its completed acquisition of 60% of Cosmix Wellness from the founders, disclosed through letters dated February 4 and February 5, 2026. The additional 20% cash purchase increases its economic holding by one-third from the initial 60% level to 80%.

The disclosure links the acquisition to Marico’s premium food and nutrition categories and to Cosmix Wellness’ digital-first functional wellness proposition. It does not provide a projected revenue target, integration timetable, product-launch plan or forecast of the effect of the 80% holding on Marico’s financial results.

Conclusion

Marico’s Rs 113.65 crore cash purchase increased its Cosmix Wellness ownership from 60% to 80% on November 6, 2026. The acquired business reported turnover rising from Rs 24.32 crore in FY 2023-24 to Rs 91.53 crore in FY 2025-26, while its disclosed last-three-month ARR was Rs 170+ crore under Ind AS.

The next disclosed point to watch is the period after FY29, when Marico has the right to acquire the remaining 20%. That outcome depends on unspecified milestones, requisite approvals and definitive-agreement terms, and the consideration for the final stake will be determined only then.